- Home
- AXSM vs USM Comparison
AXSM vs USM Comparison
Compare AXSM & USM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- USM
- Stock Information
- Founded
- AXSM 2012
- USM 1983
- Country
- AXSM United States
- USM United States
- Employees
- AXSM N/A
- USM N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- USM Telecommunications Equipment
- Sector
- AXSM Health Care
- USM Telecommunications
- Exchange
- AXSM Nasdaq
- USM Nasdaq
- Market Cap
- AXSM 6.3B
- USM 5.8B
- IPO Year
- AXSM 2015
- USM 1988
- Fundamental
- Price
- AXSM $116.63
- USM $69.21
- Analyst Decision
- AXSM Strong Buy
- USM Buy
- Analyst Count
- AXSM 14
- USM 3
- Target Price
- AXSM $168.93
- USM $86.33
- AVG Volume (30 Days)
- AXSM 566.5K
- USM 174.4K
- Earning Date
- AXSM 05-05-2025
- USM 05-02-2025
- Dividend Yield
- AXSM N/A
- USM N/A
- EPS Growth
- AXSM N/A
- USM N/A
- EPS
- AXSM N/A
- USM N/A
- Revenue
- AXSM $385,693,000.00
- USM $3,770,000,000.00
- Revenue This Year
- AXSM $65.06
- USM N/A
- Revenue Next Year
- AXSM $63.84
- USM N/A
- P/E Ratio
- AXSM N/A
- USM N/A
- Revenue Growth
- AXSM 42.53
- USM N/A
- 52 Week Low
- AXSM $64.11
- USM $33.38
- 52 Week High
- AXSM $139.13
- USM $70.49
- Technical
- Relative Strength Index (RSI)
- AXSM 41.81
- USM 63.29
- Support Level
- AXSM $117.60
- USM $68.10
- Resistance Level
- AXSM $122.97
- USM $70.49
- Average True Range (ATR)
- AXSM 4.26
- USM 1.37
- MACD
- AXSM -1.28
- USM 0.39
- Stochastic Oscillator
- AXSM 18.74
- USM 82.39
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About USM United States Cellular Corporation
United States Cellular Corp is a regional wireless carrier that serves about 4.4 million customers spread across four major geographic clusters: the Midwest, mid-Atlantic, New England, and the Pacific Northwest. These service territories encompass a total population of about 32 million people. The vast majority of the markets the firm serves are rural or second/third-tier cities, with only the greater Milwaukee and Oklahoma City regions boasting populations greater than 1 million. us Cellular also owns a 5.5% stake in Verizon Wireless' Los Angeles operations and, unlike its wireless carrier peers, owns most of its towers. The firm has agreed to sell its wireless operations and most of its spectrum licenses in a series of transactions with T-Mobile, Verizon, and AT&T.